(1) Strong management team

We have a strong management team and rich professional experience. Mr. Gao Bin is our executive chairman and the controlling shareholder of our company. He has more than 20 years experience in drug marketing in China, and he has established a strong and effective management team for our company. Half of the company's senior managers have more than 20 years of pharmaceutical business experience in China.

(2) Effective marketing team and extensive distribution network.

We have an efficient marketing team of more than 65,438+0,000 people and an extensive distribution network covering the whole of China, which enables us to quickly distribute pharmaceutical products to retailers for sale, thus enabling us and other third-party pharmaceutical products to be sold in various provinces, municipalities and autonomous regions of China. The key of our marketing strategy is to find the potential market in China and promote sales and marketing through agents or ourselves. Each sales team is responsible for coordinating the marketing activities of the company in its responsible province. These sales teams are endowed with great autonomy, which enables us to respond quickly and flexibly to the changes in different sales markets in China.

(3) Strong R&D capability.

Our company has a strong R&D capability, so we can do most R&D work within the company without seeking help from other companies and sell our own R&D results. Our powerful R&D capabilities enable us to research and develop more than 50 potential new products at the same time, and provide a strong foundation for Chang 'ao brand products. We have more than 80 researchers, and we also have a consulting team composed of six consultants, who have rich knowledge and rich experience and can assist us in product research and development.

Production process of GMP certified products

Our production process has passed GMP certification, and we implement a strict quality management system to ensure that the production process meets the standards and procedures stipulated by the state.

(5) List of National Pharmaceutical Products Plan

Australian-American products and more than 10 products of Changao brand (such as Moline, Junbiqing, Cefradine for Injection, Aoshu, Simei, Lin Kexin, Aofen, Fushitan, Li Zhixue, Libeis, Jianao, Aoweishu and Youmalin) are listed in the national basic medical insurance and industrial injury insurance drugs issued by the Ministry of Labor and Social Security of People's Republic of China (PRC).

(6) technological innovation is recognized.

The products of Chang 'ao Pharmaceutical Technology Company have been recognized by the market in terms of technological innovation.

The details of product awards and recognition of Chang 'ao Pharmaceutical Technology Company are as follows:

Date of grant, details of grant and recognition, and awarding institution.

From June 5438 to February 2007, clarithromycin dispersible tablets and amoxicillin clavulanic acid chewable tablets (7: 1) obtained the high-tech product certificate of Jiangsu Science and Technology Department.

In August, 2007, the research on the national first-class innovative drug YC- 16 of oxazolidinone was included in the Jiangsu High-tech Research Program (Medicine) of Jiangsu Science and Technology Department.

In June, 2007, Exemestane Capsule obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June, 2007, Irbesartan Tablets obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June 2007, pantoprazole sodium for injection obtained the certificate of high-tech products from Nanjing Science and Technology Bureau.

In June, 2007, azithromycin, a salt for injection, obtained the high-tech product certification certificate from Nanjing Science and Technology Bureau.

In June 2007, amoxicillin and clavulanate potassium chewable tablets (7: 1) obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June 2007, clindamycin phosphate for injection obtained the high-tech product certificate of Nanjing Science and Technology Bureau.

In June, 2007, Vitamin U Belladonna Al-Mg Capsule obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June 2007, somatostatin for injection obtained the high-tech product certificate of Nanjing Science and Technology Bureau.

In June 2007, domperidone maleate tablets obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June, 2007, Merizine Hydrochloride Tablets obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June 2007, sibutramine hydrochloride capsules obtained the high-tech product certificate from Nanjing Science and Technology Bureau.

In June, 2007, clarithromycin dispersible tablets obtained the high-tech product certificate of Nanjing Science and Technology Bureau.

In June 2007, cefoperazone sodium and sulbactam sodium for injection obtained the high-tech product certificate of Nanjing Science and Technology Bureau.

In May, 2007, the research on new dopamine anti-Parkinson's disease drugs and their industrialization was included in the project of Nanjing Science and Technology Development Plan, Nanjing Science and Technology Bureau and Nanjing Finance Bureau.

In September 2006, the research on PNA, a national innovative drug against hepatitis B nucleosides, was included in the National Natural Science Foundation project.

In June 2006, the research on PNA, a national first-class innovative drug against hepatitis B nucleosides, was included in the projects of Nanjing Science and Technology Development Plan, Nanjing Science and Technology Bureau and Nanjing Finance Bureau.

In February, 2006, the research and development of ZLR-8, a new anti-inflammatory drug among NSAIDs, was included in the technological innovation fund project of high-tech SMEs.

In May 2005, the preparation and industrialization of pemetrexed disodium freeze-dried powder were included in the Nanjing Science and Technology Development Plan of Nanjing Science and Technology Bureau.

Nanjing Municipal Bureau of Finance

In August 2004, irbesartan and tolterodine tartrate were included in the national fund plan of the first batch of national debt projects for technological progress and industrial upgrading of enterprises in Nanjing Economic Commission in 2004.

Nanjing Municipal Bureau of Finance

In July 2004, the development of ZLR-8, a new anti-inflammatory drug among non-steroidal anti-inflammatory drugs without donors, was included in the provincial science and technology development plan (tackling key problems in science and technology of three drugs).

Jiangsu Provincial Department of Finance

In July, 2004, the research on the national first-class innovative drug YC- 12 was included in the National High-tech Research and Development Plan (863 Plan), a major scientific and technological project of the Ministry of Science and Technology of China.

From June 5438 to February 2003, YC- 12, a new class of oxazolidinone antibacterial drugs, was included in the Nanjing Science and Technology Development Plan of Nanjing Science and Technology Bureau.

Nanjing Municipal Bureau of Finance

In August 2002, sibutramine hydrochloride capsules, clarithromycin dispersible tablets and pantoprazole sodium for injection were recognized as high-tech products in Jiangsu Province by the Science and Technology Department of Jiangsu Province.

In March 2002, sibutramine hydrochloride capsules won the second prize of Nanjing Municipal People's Government 200 1 Nanjing Science and Technology Progress Award.

200 1 65438+February sibutramine hydrochloride capsule won the first prize of Liuhe county scientific and technological progress 2001,Liuhe county people's government.

Pantoprazole sodium for injection, sibutramine hydrochloride capsules and irbesartan tablets were recognized as high-tech products by Nanjing Science and Technology Bureau in February.

In May 2000, Pantoprazole Sodium for Injection was awarded the title of Nanjing Excellent New Product by Nanjing Economic Commission 65438-0999.

Details of the major awards and certificates won by Nanjing Chang 'ao Pharmaceutical Co., Ltd. are as follows:

Award-winning date Award-winning and certification details awarding authority

June 5438 +2008 10 High-tech enterprise of Jiangsu Science and Technology Department.

June 5438+February 2007 Technology-intensive and knowledge-intensive enterprises of Jiangsu Science and Technology Department

High-tech enterprises recognized by Nanjing Science and Technology Bureau in September 2007

June, 5438 +2006 10 High-tech enterprises in Jiangsu Science and Technology Department.

In June 2006, Nanjing Foreign Trade and Economic Cooperation Bureau was an advanced technology enterprise with foreign investment.

In September 2005, Jiangsu Science and Technology Department was a technology-intensive and knowledge-intensive enterprise.

In March 2005 and 2004, the Nanjing Municipal Party Committee and the Nanjing Municipal People's Government of China's * * * Production Party built a new advanced unit in Nanjing.

From June 5438 to February 2004, Nanjing Foreign Trade and Economic Cooperation Bureau was an advanced technology enterprise with foreign investment.

June 2003 5438+065438+ 10 Nanjing Science and Technology Bureau, a high-tech enterprise.

In June 2003, Jiangsu Science and Technology Department was a private science and technology enterprise in Jiangsu Province.

In May 2003 and 2002, Nanjing Economic Commission, Nanjing Federation of Trade Unions, Nanjing Enterprise Federation and Nanjing Entrepreneur Association were outstanding enterprises in Nanjing.

In March 2003, in 2002, the Nanjing Municipal Committee of the Communist Party of China produced the Party and the Nanjing Municipal People's Government to build a new advanced unit in Nanjing.

June 2002: 5438+065438+ 10 High-tech enterprise of Jiangsu Science and Technology Department.

March 2000 1999 China built a new advanced unit in Nanjing, resulting in the Nanjing Municipal Committee of the Communist Party of China and the Beijing Municipal People's Government.

The main awards and certification details of Nanjing Chang 'ao Pharmaceutical Technology Co., Ltd. are as follows:

Award-winning date Award-winning and certification details awarding authority

June 5438 +2008 10 High-tech enterprise of Jiangsu Science and Technology Department.

In April, 2006, General Manager Li Zhan won the honorary title of the sixth batch of young and middle-aged industrial technology leaders in Nanjing, and was awarded the title of Nanjing Science and Technology Bureau.

June 5438+February 2005 Nanjing Science and Technology Bureau, a high-tech enterprise.

February 2005 2003-2004 People's Government of Qinhuai District, Nanjing, a civilized unit of Qinhuai District, Nanjing

In August 2004, Jiangsu Provincial Science and Technology Department recognized high-tech enterprises.

In June 2004, Nanjing Science and Technology Bureau was a private technology enterprise in Nanjing.

In March 2004, Nanjing Science and Technology Bureau, a scientific research and development institution in Nanjing.

February 2004 2003 Top Ten Private Enterprises in Qinhuai District of Nanjing Qinhuai District People's Government of Nanjing

High-tech enterprises recognized by Nanjing Science and Technology Bureau in August 2003

March 2003 2002 Top Ten Private Enterprises in Qinhuai District of Nanjing Qinhuai District People's Government of Nanjing